NSCLC biology and new therapies: Reversing resistance
5 Oct 2016
NSCLC biology and new therapies: Reversing resistance
Screening, surgical cure and new developments: Current state of the art surgery
Screening, surgical cure and new developments: Q & A
NSCLC biology and new therapies: Animal models of lung cancer
Immunotherapy in lung cancer: Q & A
Tumour heterogeneity and the impact on patient care
Screening, surgical cure and new developments: How to avoid false positives in lung cancer screening
Screening, surgical cure and new developments: How to organise a national screening programme
Omics, early detection and novel therapies: Q & A
Immunotherapy in NSCLC
Immunotherapy in SCLC
Omics, early detection and novel therapies: Metabolomics